Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Overactive Bladder Treatment Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Overactive Bladder Treatment Drugmarket, defines the market attractiveness level of Overactive Bladder Treatment Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Overactive Bladder Treatment Drug industry, describes the types of Overactive Bladder Treatment Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Overactive Bladder Treatment Drug market and the development prospects and opportunities of Overactive Bladder Treatment Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Overactive Bladder Treatment Drug market in Chapter 13.
By Player:
Laborie, Pfizer Inc
Macleod's pharmaceuticals Ltd
Astellas Pharma Inc
Apotex
Intas Pharmaceuticals
Allergan
Axonics modulation technologies
Teva Pharmaceuticals
Sanofi SA
By Type:
Anticholinergics
Solifenacin
Oxybutynin
Darifenacin
Fesoterodine
Tolterodine
Trospium
Others
By End-User:
Idiopathic Bladder Overactivity
Neurogenic Bladder Overactivity
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Overactive Bladder Treatment Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Overactive Bladder Treatment Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Overactive Bladder Treatment Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Overactive Bladder Treatment Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Overactive Bladder Treatment Drug Market Analysis and Outlook to 2022
-
7.1 Global Overactive Bladder Treatment Drug Consumption (2017-2022)
-
7.2 United States Overactive Bladder Treatment Drug Consumption (2017-2022)
-
7.3 Europe Overactive Bladder Treatment Drug Consumption (2017-2022)
-
7.4 China Overactive Bladder Treatment Drug Consumption (2017-2022)
-
7.5 Japan Overactive Bladder Treatment Drug Consumption (2017-2022)
-
7.6 India Overactive Bladder Treatment Drug Consumption (2017-2022)
-
7.7 South Korea Overactive Bladder Treatment Drug Consumption (2017-2022)
8 Region and Country-wise Overactive Bladder Treatment Drug Market Analysis and Outlook to 2028
-
8.1 Global Overactive Bladder Treatment Drug Consumption Forecast (2022-2028)
-
8.2 United States Overactive Bladder Treatment Drug Consumption Forecast (2022-2028)
-
8.3 Europe Overactive Bladder Treatment Drug Consumption Forecast (2022-2028)
-
8.4 China Overactive Bladder Treatment Drug Consumption Forecast (2022-2028)
-
8.5 Japan Overactive Bladder Treatment Drug Consumption Forecast (2022-2028)
-
8.6 India Overactive Bladder Treatment Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Overactive Bladder Treatment Drug Consumption Forecast (2022-2028)
9 Global Overactive Bladder Treatment Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Overactive Bladder Treatment Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Anticholinergics Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Solifenacin Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Oxybutynin Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Darifenacin Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Fesoterodine Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Tolterodine Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Trospium Consumption and Growth Rate (2017-2022)
-
9.1.8 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Overactive Bladder Treatment Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Idiopathic Bladder Overactivity Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Neurogenic Bladder Overactivity Consumption and Growth Rate (2017-2022)
10 Global Overactive Bladder Treatment Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Overactive Bladder Treatment Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Anticholinergics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Solifenacin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Oxybutynin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Darifenacin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Fesoterodine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Tolterodine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Trospium Consumption Forecast and Growth Rate (2022-2028)
-
10.1.8 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Overactive Bladder Treatment Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Idiopathic Bladder Overactivity Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Neurogenic Bladder Overactivity Consumption Forecast and Growth Rate (2022-2028)
11 Global Overactive Bladder Treatment Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Overactive Bladder Treatment Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Overactive Bladder Treatment Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Overactive Bladder Treatment Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Overactive Bladder Treatment Drug Market Competitive Analysis
-
14.1 Laborie, Pfizer Inc
-
14.1.1 Laborie, Pfizer Inc Company Details
-
14.1.2 Laborie, Pfizer Inc Overactive Bladder Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Laborie, Pfizer Inc Overactive Bladder Treatment Drug Product and Service
-
14.2 Macleod's pharmaceuticals Ltd
-
14.2.1 Macleod's pharmaceuticals Ltd Company Details
-
14.2.2 Macleod's pharmaceuticals Ltd Overactive Bladder Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Macleod's pharmaceuticals Ltd Overactive Bladder Treatment Drug Product and Service
-
14.3 Astellas Pharma Inc
-
14.3.1 Astellas Pharma Inc Company Details
-
14.3.2 Astellas Pharma Inc Overactive Bladder Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Astellas Pharma Inc Overactive Bladder Treatment Drug Product and Service
-
14.4 Apotex
-
14.4.1 Apotex Company Details
-
14.4.2 Apotex Overactive Bladder Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Apotex Overactive Bladder Treatment Drug Product and Service
-
14.5 Intas Pharmaceuticals
-
14.5.1 Intas Pharmaceuticals Company Details
-
14.5.2 Intas Pharmaceuticals Overactive Bladder Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Intas Pharmaceuticals Overactive Bladder Treatment Drug Product and Service
-
14.6 Allergan
-
14.6.1 Allergan Company Details
-
14.6.2 Allergan Overactive Bladder Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Allergan Overactive Bladder Treatment Drug Product and Service
-
14.7 Axonics modulation technologies
-
14.7.1 Axonics modulation technologies Company Details
-
14.7.2 Axonics modulation technologies Overactive Bladder Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Axonics modulation technologies Overactive Bladder Treatment Drug Product and Service
-
14.8 Teva Pharmaceuticals
-
14.8.1 Teva Pharmaceuticals Company Details
-
14.8.2 Teva Pharmaceuticals Overactive Bladder Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Teva Pharmaceuticals Overactive Bladder Treatment Drug Product and Service
-
14.9 Sanofi SA
-
14.9.1 Sanofi SA Company Details
-
14.9.2 Sanofi SA Overactive Bladder Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Sanofi SA Overactive Bladder Treatment Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Overactive Bladder Treatment Drug
-
Figure Overactive Bladder Treatment Drug Picture
-
Table Global Overactive Bladder Treatment Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Overactive Bladder Treatment Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Overactive Bladder Treatment Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Overactive Bladder Treatment Drug Consumption by Country (2017-2022)
-
Figure United States Overactive Bladder Treatment Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Overactive Bladder Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure China Overactive Bladder Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Overactive Bladder Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure India Overactive Bladder Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Overactive Bladder Treatment Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Overactive Bladder Treatment Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Overactive Bladder Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Overactive Bladder Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Overactive Bladder Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Overactive Bladder Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Overactive Bladder Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Overactive Bladder Treatment Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anticholinergics Consumption and Growth Rate (2017-2022)
-
Figure Global Solifenacin Consumption and Growth Rate (2017-2022)
-
Figure Global Oxybutynin Consumption and Growth Rate (2017-2022)
-
Figure Global Darifenacin Consumption and Growth Rate (2017-2022)
-
Figure Global Fesoterodine Consumption and Growth Rate (2017-2022)
-
Figure Global Tolterodine Consumption and Growth Rate (2017-2022)
-
Figure Global Trospium Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Idiopathic Bladder Overactivity Consumption and Growth Rate (2017-2022)
-
Figure Global Neurogenic Bladder Overactivity Consumption and Growth Rate (2017-2022)
-
Figure Global Anticholinergics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Solifenacin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oxybutynin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Darifenacin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Fesoterodine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tolterodine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Trospium Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Idiopathic Bladder Overactivity Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neurogenic Bladder Overactivity Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Overactive Bladder Treatment Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Overactive Bladder Treatment Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Laborie, Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Laborie, Pfizer Inc Overactive Bladder Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Laborie, Pfizer Inc Overactive Bladder Treatment Drug Product and Service
-
Table Macleod's pharmaceuticals Ltd (Foundation Year, Company Profile and etc.)
-
Table Macleod's pharmaceuticals Ltd Overactive Bladder Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Macleod's pharmaceuticals Ltd Overactive Bladder Treatment Drug Product and Service
-
Table Astellas Pharma Inc (Foundation Year, Company Profile and etc.)
-
Table Astellas Pharma Inc Overactive Bladder Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharma Inc Overactive Bladder Treatment Drug Product and Service
-
Table Apotex (Foundation Year, Company Profile and etc.)
-
Table Apotex Overactive Bladder Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Apotex Overactive Bladder Treatment Drug Product and Service
-
Table Intas Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Intas Pharmaceuticals Overactive Bladder Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Intas Pharmaceuticals Overactive Bladder Treatment Drug Product and Service
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Overactive Bladder Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Overactive Bladder Treatment Drug Product and Service
-
Table Axonics modulation technologies (Foundation Year, Company Profile and etc.)
-
Table Axonics modulation technologies Overactive Bladder Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Axonics modulation technologies Overactive Bladder Treatment Drug Product and Service
-
Table Teva Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceuticals Overactive Bladder Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceuticals Overactive Bladder Treatment Drug Product and Service
-
Table Sanofi SA (Foundation Year, Company Profile and etc.)
-
Table Sanofi SA Overactive Bladder Treatment Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi SA Overactive Bladder Treatment Drug Product and Service
-
